Standard Chartered CEO Apologizes for Calling Some Employees Lower Value Human Capital Americans Raid Emergency Savings to Cover Gas Costs Amid Energy Price Surge Bitcoin Dips Below 76K as Geopolitical Risks and ETF Outflows Weigh on Sentiment Batam Emerges as a Key Destination for Chinese Companies Singapore Remains Leading Investor T1 Energy TE Surges Over 42 as Analyst Optimism Outweighs ShortSeller Concerns Trainline Lifts FullYear Guidance for Second Time in 2025 Signaling Sustained Momentum ERAS Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower PG Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher IDCC Q1 2026 Earnings EPS Beats Estimates by 2269 Shares Dip Despite Strong Profit Performance EXC Q1 2026 Earnings EPS Beat Driven by Operational Strength and Favorable Weather BTGO Q1 2026 Earnings Significant Earnings Miss Drives Stock Decline ALEC Q1 2026 Earnings NarrowerThanExpected Loss Surprises No Revenue Yet Netclass Technology Inc NTCL Surges 45 Key Levels and Momentum in Focus Bayview Acquisition Corp Right BAYAR Holds Steady at 016 Key Levels in Focus Group 1 Automotive GPI Edges Higher Near Resistance Key Levels and Market Dynamics Renatus Tactical Acquisition Corp I RTAC Holds Steady Near Resistance Key Levels in Focus Vera Therapeutics VERA Consolidates Near Support After Slight Decline US Stock Futures and Bond Yields Decline Amid Reports of Putins Updated Nuclear Doctrine Inflation Pressures Persist as Americans Face Higher Travel Food and Recreation Costs Ahead of Holiday Weekend Chace Crawford Pitches The Deep Spinoff Could Expand Amazons The Boys Universe Huawei Eyes New Smartphone Chips This Fall as Tech Rivalry Intensifies California State of Emergency Declared Over Methyl Methacrylate Leak Potential Chemical Sector Disruptions Charter Communications Enhances Offer for Liberty Broadband in Revised Buyout Deal Steel Stocks Rally on Government Extension of Minimum Import Price on 66 Products Polestar Q4 2024 Earnings Massive EPS Miss Highlights Mounting Losses Stock Slides Trevi Therapeutics TRVI Shows Potential as Shares Climb Over 2